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Abstract 12-O-Tetradecanoylphorboi 13-acetate (TPA) elic- 
ited a transient increase in the transcription of the inducible nitric 
oxide synthase (iNOS) gene coupled with a shortening of the 
half-life of its mRNA in primary neonatal rat hepatocytes. These 
effects of TPA were preceded by a surge in nuclear translocation 
of the transcription factor NF-IcB, and followed by a mounting 
accumulation of NO~ in the growth medium. Even cycloheximide 
(CHX) added by itself elicited an early, sustained activation of 
NF-KB followed by an intense induction of iNOS gene expres- 
sion, irrespective of what degree of protein synthesis inhibition 
was brought about by the several concentrations tested. When 
given together, TPA and CHX exerted additive effects on hepa- 
tocellular iNOS mRNA levels. These results suggest he likeli- 
hood of an ordered sequence of events by which an activated 
NF-KB mediates the induction of iNOS gene expression in TPA- 
and/or CHX-treated primary hepatocytes. 
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1. Introduction 
Several ines of evidence attest he involvement of the nitric 
oxide (NO) pathway in the functional regulation of any organ 
and tissue in the body [1 3]. This gaseous compound performs 
its complex tasks by acting as an intra- or extracellular messen- 
ger molecule [2,4]. NO is generated from L-arginine by the 
activity of distinct enzymes, i.e. two constitutive and one induc- 
ible synthases (cNOS and iNOS, respectively), which may not 
be all expressed in the same cells [1]. Moreover, each type of 
tissue or cell appears to be endowed with a distinct assortment 
of mechanisms governing the induction of iNOS gene expres- 
sion [1,3]. As to the liver, some cNOS activity is normally 
detectable in Kupffer cells, whereas no cNOS is ever encoded 
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in hepatocytes [5]. On the other hand, both main types of 
hepatic cells and Ito cells too are prompted to express an in- 
tense iNOS activity once exposed to effective stimuli, e.g. bac- 
terial lipopolysaccharide (LPS) along with mixtures of cytoki- 
nes such as tumor necrosis factor-s, interleukin-1, and inter- 
feron-y (IFN-y) [6--8]. A chronic inflammatory process trik- 
ing the liver also effectively induces iNOS activity [9]. The 
import of NO biosynthesis by Kupffer cells and by hepatocytes 
in key pathophysiological processes, uch as inflammation and 
defence against he invasion by infectious micro-organisms or
malignant tumour cells, is only beginning to be clarified [5,10]. 
Various studies have reported the presence of two binding 
sites for the transcription factor NF-lcB in the sequence of the 
promoting region of iNOS gene, thereby implicating such a 
factor in the modulation of its transcription i  cell types unre- 
lated to the liver [11-14]. Notably, NF-xB is constitutively 
existent as an inactive cytoplasmic heterotrimeric complex that 
can be activated by proper stimuli via a post-translastional 
phosphorylation mechanism involving several kinases - but no 
new protein synthesis - leading to the dissociation of NF-xB 
from cytosolic IxB proteins; released NF-xB is then able to 
translocate into the nucleus, where it binds to specific DNA 
sequences [13-15]. The role(s) played by NF-xB in the modula- 
tion of the expression of iNOS gene by mammalian hepatocytes 
still remain(s) to be fully clarified. 
Primary cultures of adult hepatocytes were used as a model 
system to investigate some facets of the process of iNOS induc- 
tion by mixtures of LPS with cytokines [9,16,17]. Conversely, 
other types of reportedly effective inducers (e.g. phorbol esters) 
have hitherto attracted much less attention [18]. Moreover, the 
likelihood that iNOS inducing agents and/or the susceptibility 
to them of either hepatocytes or Kupffer cells or of both may 
vary along with the several stages of life has hitherto been, as 
far as we know, neglected. Therefore, we endeavoured tothrow 
further light onto the mechanisms modulating the induction of 
iNOS activity elicited by the well-known tumor promoting 
agent TPA by using as an experimental model neonatal rat 
hepatocytes set into pure primary cultures. In previous papers, 
we showed that TPA enhances the proliferation of the primary 
neonatal hepatocytes by activating a rather complex panel of 
operative mechanisms [19,20]. In this communication, we re- 
port that TPA and the protein synthesis inhibitor CHX can 
both function, either singly or in an additive fashion, as fully 
effective super-inducers of iNOS gene expression in neonatal 
rat hepatocytes kept in synthetic growth medium. Additionally, 
an increased translocation of NF-~cB into the nuclei antecedent 
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the enhancement over baseline levels of the transcription of 
iNOS mRNA on the part of TPA and/or CHX has been ob- 
served for the first time in the same hepatocytes, uggesting that 
these two processes may be tightly connected. 
2. Materials and methods 
2.1. Chemicals 
All the chemical agents used were from Sigma Chemical Co. (St. 
Louis, MO), unless otherwise specified. All solutions and growth media 
were made up with ultrapure water produced by a combined Milli-Ro 
and Milli-Q UF system (Millipore S.p.A., Milan). 
2.2. Neonatal rat hepatocyte and HeLa cell cultures 
Livers were removed from 2- to 4-day-old Wistar rats (S. Morini, 
S.a.s., San Polo d'Enza, RE), pooled, and set into primary cultures as 
previously detailed [21]. Briefly, neonatal liver cells were isolated both 
mechanically and enzymatically, and hepatocytes were next separated 
from blood and stromal cells, dead cells, cell debris, collagen fibers, and 
large cell clumps in a Percoll (Pharmacia S.p.A., Milan) gradient [21]. 
The purified hepatocytes (96-98% of the cell total population) were 
resuspended in synthetic HiWosBa2ooo medium, which contained 1.0 
× 10 -3 M Ca ~÷ and 7.5 mg/1 ornithine instead of arginine [21]. Just 
before use, 50 IU/ml streptomycin (Squibb & Sons S.p.A., Rome), 5.35 
/tg/ml imipenem onohydrate (Sigma Tau S.p.A., Rome), 5.35 ,ug/ml 
sodium cilastatin (Sigma Tau), and 250 ng/ml fungizone (Mascia- 
Brunelli S.p.A., Milan) were added to this medium. Once their numbers 
had been assessed, the hepatocytes were diluted to a final concentration 
of 1.0 × 106/ml, and planted in 6-well cluster plates (Costar Italia, S.r.l., 
Milan) at 0,5 x 10 6 cell/well. At the bottom of each well was a non-toxic, 
ultrathin (37.5 pm), porous polyethylene disc (Visqueen Ltd., London, 
UK), the upper cell-receiving surface of which had been coated with a 
film of type I collagen. Before planting the hepatocytes, the collagen- 
coated iscs were covered with a culture medium consisting of 90% v/v 
HiWosBa2ooo medium and 10% v/v inactivated, ialysed fetal bovine 
serum (FBS, ICN-Flow S.p.A., Milan), which contained 10 ng/ml epi- 
dermal growth factor (EGF), 100 pM glucagon, 5.0/.tg/ml insulin, and 
0.4 ,ug/ml hydrocortisone, as well as 1.12 g/l NaHCO 3. The cultures 
were incubated at 37°C in humidified 95% air/5% CO2 mixture. At 24 
hours, the porous discs onto which the hepatocytes had been planted 
were removed from the wells and floated cell-side down on the surface 
of a fresh medium consisting of 5% v/v FBS and 95% v/v Eagle's 
Minimum Essential Medium (MEM) with NaHCO3 but without EGF, 
glucagon, hydrocortisone, and insulin. At 48 hours, this medium was 
discarded and replaced with serum-free and hormones-free Eagle's 
MEM medium with NaHCO3. 
HeLa cells were cultured under standard conditions in Dulbecco's 
modified MEM medium (Gibco-BRL S.p.A., Milan) fortified with 10% 
(v/v) FBS, antibiotics, and glutamine. 
2.3. Experimental procedures 
Experiments using primary neonatal rat hepatocyte cultures were 
started on the fourth day of staying in vitro. Control specimens were 
exposed to fresh, serum-free, EGF- and hormones-free MEM medium. 
The experimental cultures were divided into several groups and received 
a change of the same medium as used for the controls except for 
containing TPA (10 -9 M). In another set of experiments, several doses 
of either CHX (from 0.25 to 25 pg/ml) or pyrrolidine dithiocarbamate 
(PDTC; from 10 -8 to 10 -3 M) - a reputedly specific inhibitor of NF-xB 
[13] - were added to the fresh synthetic medium 15 min and 1 hour, 
respectively, before administering TPA to the primary hepatocytes. As 
shown in a pilot experiment, CHX used singly at 25 /~g/ml totally 
inhibited the macromolecular incorporation of [3H]leucine by the pri- 
mary hepatocytes, whereas CHX at 0.25/.tg/ml was unable to change 
the rate of ongoing protein synthesis in the same cells. In further 
experiments, actinomycin D (Act. D, 5.0/~g/ml) was administered to
both untreated (control) and TPA-treated (10 -9 M for 3 hours) liver 
cultures. This dose of Act-D completely hindered the macromolecular 
incorporation of [3H]uridine by the cultured hepatocytes in a pilot 
experiment. 
Primary neonatal hepatocyte cultures were sampled at predetermined 
times after the onset of the various treatments, and the corresponding 
total cellular RNA's and nuclear extracts were prepared as detailed 
below. NO~- concentrations were also determined in the conditioned 
growth media pertaining to some of the above experiments. 
Confluent HeLa cell cultures were divided into three groups: the first 
received only a change of fresh medium; the second was exposed to 5.0 
× 10 -8 M TPA for 1.0 hour; and, the third was preincubated for 1 hour 
with PDTC (from 1.0 × 10 -6 to 2.0 × 10 -4 M) before adding 5.0 × 
10 -8 M TPA. Nuclear extracts were prepared from the specimens thus 
collected (see below). 
2.4. Northern blot analysis 
Total RNA was extracted by the guanidine thiocyanate/cesium chlo- 
ride method [22]. Samples of 20 pg of total RNA were separated by 
electrophoresis on 1.0% agarose gel in MOPS buffer, blotted into a 
Hybond N membrane (Amersham, Milan), and hybridised with the 
cDNA either for rat iNOS [23] or for v-fos previously labelled by means 
of a Megaprime DNA labelling system (1.0-2.0 × 10 9 cpm/pg; Amer- 
sham). The amounts of specific mRNA were measured in a Phosphor 
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Pig. I. (A) The induction ofiNOS and ofe-fos gene expression by TPA 
in primary neonatal rat hepatocytes. Details on the culture procedure, 
experimental treatment, and Northern analysis are given in section 2. 
The bottom panel shows the ethidium bromide staining of the same gel 
shown both in the intermediate and top panels prior to undergoing the 
blotting procedure. 28 S and 18 S mark the levels of the corresponding 
ribosomal RNA species. (B) The time-related changes in the amount 
of NO~ assayable in the synthetic MEM medium per million of 
primary neonatal rat hepatocytes after the onset of the exposure to TPA 
00 -9 M). The points are the mean values from two distinct 
experiments. 
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Imager SF (Molecular Dynamics, Milan). In those experiments in
which iNOS mRNA half-lives were assessed, control and 3-hour TPA- 
pre-pretreated rat hepatocytes were incubated with Act. D (5.0/tg/ml) 
for up to 4 hours, and the declining steady-state levels of the specific 
mRNA were monitored by Northern analysis in the corresponding 
samples. 
2.5. Electrophoretic mobility shift assay (EMSA ) 
Nuclear extracts were prepared according to Schreiber et al. [24] in 
the presence of 10/lg/ml leupeptin, 5.0 ~tg/ml antipain, 5.0/~g/ml pep- 
statin, and 1.0 mM PMSF. The protein concentration f the nuclear 
extracts was determined according to Bradford [25]. A sample (8.0/lg) 
of each nuclear extract was incubated at room temperature for 30 min 
with either of two 32P-labelled double stranded oligonucleotides (0.2 ng, 
corresponding to about 2.0-5.0 × 104 cpm), of which one contained 
a consensus NF-~cB DNA binding site (5'-GATCCAGAGGGGACT- 
TTCCGAGTAC-Y; a gift from Dr. M. Merola) and the other an AP-1 
DNA binding site (5'- CTAGTGATGAGTCAGCCGGATC-Y; a gift 
from Dr. G. Rigaud), in 15/11 of a reaction mixture made up by 20 mM 
HEPES pH 7.9, 50 mM KC1, 0.5 mM DTT, 0.1 mM EDTA, 2.0/lg 
poly(dI-dC) (Pharmacia S.p.A., Milan), 1.0/tg salmon sperm DNA, 
and 10% glycerol. Products were fractionated on a non-denaturing 5%
polyacrylamide g l. In competition assays, a 100-fold amount of 'cold' 
oligonucleotide competitor was added 15 min ahead of administering 
the respective labeled probe. The corresponding intensities of the re- 
tarded bands were measured in a Phosphor Imager SF (Molecular 
Dynamics, Milan). 
2.6. Determination f NO~ in the growth media 
NO~ concentrations were assayed in phenol red-free hepatocyte- 
conditioned growth media at various time points after the addition of 
TPA (10 -9 M). After reacting with Griess's reagent [26], a 400/tl aliquot 
of each sample was mixed with an equal volume of 1.0% sulphanilamide 
and 0.1% N-(1-naphthyl)ethylenediamine-dihydrochloride; fol winga
10 min incubation at room temperature, the optical absorbance values 
of the samples were read at 540 nm in a DU 7 spectrophotometer 
(Beckman, Milan), and next correlated with the actual hepatocytes' 
numbers in the corresponding cultures on floating polyethylene discs. 
3. Results 
3.1. Super-induction of iNOS mRNA by TPA in primary 
neonatal rat hepatocytes 
Neonatal rat hepatocytes set into pure primary cultures kept 
in synthetic MEM medium were consistently found, after 4 
days of staying in vitro, to spontaneously express discrete basal 
levels of iNOS mRNA (Fig. 1A, top panel). The addition of 
TPA (10 -9 M) to this same medium could elicit a striking in- 
crease (i.e. mean: 6-fold, and range: from 4- to 20-fold in 8 
distinct experiments) in the steady-state l vels of the hepato- 
cytic iNOS transcript, which peaked between 2 and 3 hours, 
slowly dwindled thereafter, and returned to the spontaneous 
baseline values by about 24 hours (Fig. 1A, top panel). When 
the same blots used to detect iNOS mRNA signals were re- 
hybridized with a v-fos radioactive cDNA probe, it became 
manifest hat the untreated primary hepatocytes did not ex- 
press the c-fos transcript at all, whereas the TPA-exposed ones 
exhibited the general kinetics of c-fos mRNA induction, that 
is a discernible c-fos signal peaking at 30 min and totally disap- 
pearing after the first hour (Fig. 1A, intermediate panel). 
3.2. Half  lives of basal and TPA-stimulated hepatocellular iNOS 
transcripts 
As the TPA-elicited surge of iNOS mRNA we observed 
might have been brought about by a lengthening of the half-life 
of the spontaneously expressed transcript rather than by a true 
super-induction of this gene, the half-lives of iNOS mRNA's  
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Fig. 2. Top panel. Northern blot analysis of iNOS transcript after the 
addition of Act. D (5.0/lg/ml) for up to 4 hours to the medium of either 
untreated or3-hour TPA-pre-treated pure primary cultures of neonatal 
rat hepatocytes. Intermediate panel. The ethidium bromide staining of 
the corresponding gel prior to its blotting is shown. 28 S and 18 S are 
as in Fig. 1. Bottom panel. Semilogarithmic plot of the decay rates of 
iNOS transcripts in untreated (©) and in TPA-treated ($) primary 
hepatocytes after the addition of Act. D (5.0pg/ml). The corresponding 
half-lives are 7.2 hours for the controls and 1.9 hours for the 3-hour 
TPA-pre-treated specimens, respectively. The points are the means 
from three different experiments. 
had to be assessed under both untreated and phorbol ester- 
treated conditions. Thus, the spontaneously expressed iNOS 
transcript was found to dwindle rather slowly and to have a 
calculated half-life of 7.2 hours in the control hepatocytes, 
whereas its levels declined much more rapidly in TPA-pre- 
incubated hepatocytes with a half-life of 1.9 hours only (Fig. 
2). Hence, TPA simultaneously exerted two distinct actions, 
since it both super-induced the expression of the iNOS gene and 
remarkably decreased the half-life of its transcript. 
3.3. Levels of NO~ in primary hepatocytes" growth media 
The basal production of NO by the untreated (control) hepa- 
tocytes and its subsequent diffusion into the extracellular envi- 
ronment were mirrored by the steady presence of discrete levels 
of NO2 in the conditioned synthetic media to which the par- 
enchymal liver cells had been exposed (Fig. 1B). The addition 
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of TPA (10 -9 M) nearly did not change, with respect to parallel 
controls, the media's NO2 concentrations i  the course of the 
first 4 hours; subsequently, the NO~ levels increased swiftly 
between the 4th and the 8th hour and rather more gradually 
up to the 24th hour (Fig. 1 B). 
3.4. Super-induction of  iNOS gene expression by CHX in 
primary neonatal rat hepatocytes 
To throw light onto the operative mechanism(s) underlying 
the TPA-elicited enhancement of iNOS mRNA transcription, 
we endeavoured to find out whether this action of the phorbol 
ester did depend upon the de novo synthesis of some specific 
protein(s). Thus, a 15 min pre-treatment of he primary hepato- 
cytes with a concentration f CHX (i.e. 25/,tg/ml) fully inhibit- 
ing their protein synthesis could not impede the subsequent 
super-induction f iNOS transcript evoked by TPA (10 .9 M) 
(Fig. 3A). Unexpectedly, the same CHX dose given by itself was 
A 
CHX (25 ~tg/ml) - + + 
TPA + + 
iNOS 
B 
S 
S 
CHX (I.tg/ml) 0 0.25 2.5 25 
iNOS 
IS 
IS 
Fig. 3. (A) Both the super-induction f iNOS gene xpression by either 
TPA (10 .9 M) or CHX, each used by itself, and the additive induction 
of the same transcript brought about by the association ofCHX with 
TPA in the primary neonatal rat hepatocytes are shown here as the 
results of one representative experiment. (B) The nearly equivalent 
effectiveness of three different doses of CHX on the super-induction f 
iNOS gene xpression i  primary hepatocytes. In both panels A and B, 
the ethidium bromide stainings of the corresponding gels are also 
shown. 28 S and 18 S are as in Fig. 1. 
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Fig. 4. EMSA analysis of nuclear extracts of primary neonatal rat 
hepatocytes showing the activation of NF-xB occurring spontaneously 
or brought about by an exposure to either TPA (10 .9 M) or CHX (25.0 
pg/ml). Lane 1, untreated parallel controls; lanes 2M, specimens treated 
with TPA for 0.5, 1.0, and 2.0 hours, respectively; ane 5, specimen 
exposed to CHX for 2.0 hours; lane 6, a 100-fold concentration f
non-specific unlabelled oligonucleotide (e.g., AP-1) was added to nu- 
clear extracts treated as those in lane 3, 15 rain prior to the administra- 
tion of the specific labelled probe; lane 7, a 100-fold concentration f 
the specific unlabelled oligonucleotide was added to the nuclear extracts 
treated as those in lane 3 15 min prior to the administration f the 
specific labelled probe. 
found to be able to induce iNOS gene expression and, moreo- 
ver, to exert, when added along with TPA, an almost additive 
enhancing effect on the steady-state levels of iNOS transcript 
(Fig. 3A). Thus, by averaging the results of three distinct exper- 
iments, TPA (10 -9 M) by itself elicited a 6-fold increase (over 
controls' baseline) in iNOS mRNA steady-state l vels; CHX 
used alone (25 pg/ml) effected an 11-fold increase of this same 
transcript, and the corresponding TPA plus CHX mixture lic- 
ited a 15-fold increase of this mRNA, that is a nearly additive 
outcome. Moreover, two lower concentrations (i.e., 2.5 and 
0.25/,tg/ml) of CHX alone were also tested and found to super- 
induce iNOS mRNA transcription as effectively as did the 
10-or 100-fold higher dose of CHX (Fig. 3B), even though when 
given at 0.25 pg/ml this agent did not change the rate of ongoing 
protein synthesis in hepatocytes (data not plotted). 
3.5. Nuclear transcription factors and iNOS gene expression 
A basal evel of activated, i.e. DNA-bound NF-xB was de- 
tectable by EMSA in the nuclear extracts of untreated (control) 
primary neonatal rat hepatocytes (Fig. 4, lane 1) that were also 
simultaneously expressing basal steady-state l vels of iNOS 
mRNA (Fig. 1A, top panel). The exposure to TPA (10 -9 M) 
further increased the level of activated NF-~cB in the nuclear 
extracts of the primary hepatocytes, an effect peaking at 1 hour 
and completely vanishing by 2 hours (Fig. 4, lanes 2-4). Be- 
sides, even CHX (25/,tg/ml) used by itself was found to elicit 
an extra increase in the translocation of NF-xB into the nu- 
cleus: yet, at variance with TPA's action, this effect of CHX was 
still close to its peak at 2 hours (Fig. 4, lane 5). 
The anti-oxidant agent PDTC has been widely used as a 
specific inhibitor of NF-xB activation in various kinds of non- 
hepatic ells [13,27-29]. Surprisingly, none of the several doses 
(from 10 _8 to 10 -3 M) of PDTC we tested by adding them to 
the synthetic MEM medium 1 hour earlier than TPA (10 -9 M) 
could suppress either the prior activation of NF-xB (Fig. 5, left) 
or the later induction of iNOS gene expression i  the primary 
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Fig. 5. The inability of several concentrations of the anti-oxidant agent 
PDTC, added to the growth media of primary hepatocytes 1 hour prior 
to the onset of the exposure to TPA, to hinder the activation of NF-xB 
brought about by the phorbol ester (left) and, conversely, the ability of 
a single dose (i.e. 10 5 M) of PDTC to super-activate AP-1 in the same 
cells (right). It should be noted that even other doses of PDTC besides 
those shown here, that is from 10 -6 M to 10 -8 M, were also similarly 
tested and found to be unable to change the TPA-elicited activation of 
NF-xB in neonatal hepatocytes (data not shown). 
rat hepatocytes (data not shown). However, one of the PDTC 
concentrations tested (i.e. 1.0 × 10 -5 M) was found to further 
enhance the activation of AP-1 transcription factor evoked by 
TPA in the same hepatocytes (Fig. 5, right). At variance with 
its actions in the rat hepatocytes, PDTC given at doses of 1.0 
x 10 -4 M or 2.0 x 10 -4 M could fully bar the activation of 
NF-xB otherwise licited by TPA alone (5.0 x 10 -8 M) in HeLa 
cells (Fig. 6, left). Moreover, when administered at either 5.0 
x 10 -5 M or 1.0 x 10 -4 M, PDTC was also found to further 
enhance the TPA-evoked activation of AP-1 factor in the same 
HeLa cells (Fig. 6, right). 
4.  D iscuss ion  
The present results show that both the archetypal tumor 
promoting phorbol ester TPA and the notorious protein syn- 
thesis inhibitor CHX can efficiently boost both the nuclear 
translocation of NF-xB and the expression of iNOS gene in 
primary neonatal rat hepatocytes. 
To begin with, our findings confirm the previous observation 
that untreated primary hepatocytes spontaneously express low, 
yet discrete basal levels of iNOS transcript [30]. As ultrapure 
water was used to clean any piece of equipment and to make 
up any growth medium or solution coming into contact with 
these cells, it is conceivable that the spontaneous iNOS gene 
expression observed was not brought about by the exposure to 
any contaminating bacterial endotoxin(s). Because the neonatal 
rat liver tissue was previously found by us to transcribe no 
iNOS mRNA in vivo [30], we suspect hat the artificial condi- 
tion(s) inherent o the in vitro environment operate as weak 
inducer(s) of the hepatocytic iNOS gene. Furthermore, the un- 
varying presence of a fraction of actively cycling neonatal hepa- 
tocytes in the primary cultures [19,20] is unlikely to be in any 
way related to the basal expression of iNOS transcript, as a 
growth fraction of similar size is also constantly detectable in 
the neonatal rat liver tissue in vivo, which normally does not 
have any iNOS transcript [30]. Moreover, we wish to s tress that 
the primary neonatal hepatocytes were experimentally used in  
the complete absence of the serum. Hence, an intracellular 
repressor induced by a serum factor may conceivably present 
the basal expression of hepatocytic NOS gene in vivo. Another 
possibility not to be overlooked is that in vivo non-parenchy- 
mal liver cells produce a paracrine factor suppressing the iNOS 
gene expression in hepatocytes. 
The present results also show that TPA by itself significantly, 
even though transiently, amplified the basal expression of iNOS 
gene in the primary neonatal hepatocytes. Notably, TPA could 
act as a complete iNOS mRNA-inducing factor, not needing 
any co-operative agent, in these purified hepatocytic ultures, 
i n  which the fraction of non-parenchymal cells did not exceed 
a 2-4% of the total cellular population. Therefore, the super- 
induction of iNOS gene expression and the subsequent increase 
in the synthesis and extracellular liberation of NO elicited by 
the phorbol ester were all neonatal hepatocyte-specific re- 
sponses. The sharp increase in the rate of accumulation of NO~ 
in  the serumless growth media we observed to occur between 
the 4th and the 8th hour of treatment with TPA is consistent 
with a heightened level of enzymatic activity due to an ex- 
panded population of iNOS molecules encoded under an in- 
creased availability of their specific transcript. On the whole, 
these findings are in keeping with alike inducing effects on 
iNOS activity elicited by TPA in primary cultures of adult rat 
hepatocytes, as reported by Hortelano et al. [18]. 
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Fig. 6. The ability of PDTC given at 2.0 x 10 -4 M or 1.0 × 10 -4 M 
to completely suppress the activation of NF-xB otherwise brought 
about by TPA (5.0 × 10 -8 M) in HeLa cells (left), and the super- 
activation of the binding of AP-1 to DNA by PDTC at 5.0 × 10 -5 M 
or 1.0 × 10 -4 M in the nuclear extracts from the same cells (right). 
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Although the regulation of the expression of iNOS gene is 
believed to take place mainly at the transcriptional level 
[3,12,31,32], few reports have dealt with the actual stability of 
the transcript of this gene [3]. Previous data from other labora- 
tories suggested that the mechanisms involved in such a control 
might differ both at the level of the transcription and of the 
stability of iNOS mRNA according to the cell type (e.g. 
RAW264.7 cells, mouse peritoneal macrophages, Swiss 3T3 
cells) and the primary inducing agent (i.e. LPS, IFN-y, TGF-fl) 
considered [33-35]. As our findings show, TPA concurrently 
both super-induced the transcription and shortened the half-life 
of iNOS mRNA in the primary neonatal rat hepatocytes. 
Therefore, the extra increase in steady-state l vels of iNOS 
transcript brought about by TPA resulted from a quite remark- 
able surge in its rate of synthesis, which largely et temporarily 
overcame the concurrent notable shortening of the half-life of 
this same mRNA species also elicited by the phorbol ester. 
Unquestionably, TPA did behave in our model as an effective 
super-inducer of iNOS mRNA transcription even in the pres- 
ence of a dose of CHX (i.e. 25/lg/ml) capable of completely 
inhibiting the ongoing hepatocellular p otein synthesis. On the 
other hand, CHX even by itself could similarly operate as a 
complete and efficient inducer of iNOS gene expression in the 
primary hepatocytes independently on the dose tested and, 
hence, on its effects on protein synthesis. In this regard, it has 
been postulated that CHX can induce the overexpression of
specific genes by means of different mechanisms: (i) it hinders 
at inhibitory concentrations the de novo synthesis of short-lived 
proteins capable of repressing ene transcription, and/or (ii) it 
dose-independently and directly favours gene transcription i
a TPA-like fashion, via the rapid and sustained phosphoryla- 
tion of phosphoproteins [36,37]. As to the latter mechanism, 
CHX given to non-hepatic cells was reported to enhance pro- 
tein kinase-mediated phosphorylation f cytosolic IxB proteins 
and, hence, the release and translocation of NF-xB into the 
nucleus [38]. Interestingly, the activation of NF-xB by some 
agents (e.g. LPS with or without IFN-y) has been linked to the 
subsequent transcription of iNOS mRNA in several types of 
non-hepatic cells, including macrophage-like RAW264.7 cells, 
type II airway epithelial A549 cells, and insulin-producing RIN 
cells [12,27,39]. The present results how that a surge of nuclear 
NF-xB activity over its controls' baseline levels is a relatively 
early and transient (i.e. peak at 1 hour rapidly waning thereaf- 
ter) effect elicited by TPA in the primary neonatal rat hepato- 
cytes, just as it is in other phorbol ester-treated non-hepatic cell 
types [40]. Therefore, it is tempting to assume that a prior 
activation of NF-xB be a step necessary for the induction of 
iNOS gene expression even in the primary neonatal rat hepato- 
cyte model. Moreover, our data make evident hat CHX too 
is by itself an efficient activator of NF-xB in the cultured neo- 
natal hepatocytes, and that the surge of intra-nuclear NF-xB 
elicited by CHX distinctly outlives that evoked by TPA (cf. 
lanes 4 and 5 in Fig. 4). Conceivably, TPA and CHX might 
either activate different nuclear transcription factors or act 
upon the same transcription factor in the neonatal rat hepato- 
cytes. The latter view seems however to be better suited to 
explain our findings, as a more persistent activation of NF-xB 
brought about by the combination of a shorter-lasting effect of 
TPA with a longer-enduring action of CHX may account for 
the additive ffects exerted on iNOS mRNA transcription by 
an association of these two agents. 
In an endeavour to substantiate the hypothesis that an earlier 
NF-xB activation be linked to a later iNOS gene expression i  
the TPA-treated neonatal hepatocytes, we tested the effects of 
PDTC - a commonly used inhibitor of NF-lcB activation in 
various non-hepatic cell types [13,27,29] - on both these proc- 
esses. Unexpectedly, PDTC was found to be totally unable to 
hinder both NF-xB super-activation a d iNOS gene hyper- 
expression in the TPA-treated primary hepatocytes, even 
though at 10 -5 M PDTC could simultaneously activate the 
AP-1 transcription factor in these same cells. This super-activa- 
tion of AP-1 elicited by a mixture of TPA and PDTC in the 
primary hepatocytes would suggest that a sufficient amount of 
the latter agent reached and/or entered the cells in a chemically 
active form, even though PDTC was not able to prevent he 
activation of NF-xB by TPA. Conversely, in keeping with 
Meyer et al. [40], we found that the anti-oxidant PDTC could 
fully prevent the nuclear translocation ofNF-xB elicited by the 
pro-oxidant TPA in HeLa cells (cf. Fig. 6), in which the TPA- 
evoked activation of AP- 1 was instead enhanced by PDTC. On 
the whole, these results are consistent with those reported by 
others in non-hepatic cells [40,42], and indicate that the neona- 
tal hepatocytes' TPA-stimulated protein kinase C makes use of 
different intracellular signalling pathways in order to activate 
distinct ranscription factors such as NF-xB and AP-1. Such 
results authorise a warning notice about using PDTC as a 
general, specific inhibitor of NF-xB activation to invoke the 
requirement of the latter factor for the expression of certain 
genes [41]. The likely manifold biological effects of PDTC have 
not, as yet, been completely clarified. Reportedly, PDTC che- 
lates heavy metals, exerts an anti-oxidant action on account of 
its dithiocarboxy group, and may break up forming carbon 
disulphide, a compound reacting with amino groups in proteins 
(see for references: [41]). As shown by the present results, the 
effectiveness of PDTC as an inhibitor of NF-xB activation is 
not universal, but rather is likely to rest upon the specific type 
of cell considered. Hence, we conclude that TPA activates NF- 
xB in the primary neonatal rat hepatocytes by means of a 
signalling pathway that neatly differs from that it uses for the 
same purpose in HeLa cells. 
In conclusion, the present findings show that TPA increases 
the levels of iNOS mRNA by a transcriptional activation mech- 
anism and that this effect is transient inasmuch as the phorbol 
ester also shortens the half-life of the same transcript. Moreo- 
ver, since the inducing effect of TPA does not require new 
protein synthesis, a directly available transcription factor is 
likely to be involved. Accordingly, a good candidate factor 
would be NF-xB, the activation and nuclear translocation of 
which we found to be enhanced by TPA prior to the induction 
of iNOS gene transcription i  the primary neonatal hepato- 
cytes. However, the existence of a causative relationship be- 
tween these last two actions of TPA, though likely and appeal- 
ing as it may seem to be, remains to be proven for the reason 
that PDTC, the most commonly used inhibitor of NF-xB acti- 
vation in other types of non-hepatic cells, was found by us to 
be ineffective under this regard in the cultured rat hepatocytes. 
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